These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25499851)

  • 1. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway.
    Chen PM; Cheng YW; Wu TC; Chen CY; Lee H
    Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
    Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
    Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis.
    Wang Y; Yue B; Yu X; Wang Z; Wang M
    World J Surg Oncol; 2013 Jan; 11():12. PubMed ID: 23339680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nuclear factor-κB activity enhanced chemosensitivity to cisplatin in human lung adeno-carcinoma A549 cells under chemical hypoxia conditions.
    Li F; Huang L; Su XL; Gu QH; Hu CP
    Chin Med J (Engl); 2013; 126(17):3276-82. PubMed ID: 24033949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
    Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
    Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
    Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
    Oncogene; 2015 May; 34(19):2505-15. PubMed ID: 24998847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
    Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
    Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
    Li Y; Xing D; Chen Q; Chen WR
    Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition.
    Cheng Q; Lee HH; Li Y; Parks TP; Cheng G
    Oncogene; 2000 Oct; 19(42):4936-40. PubMed ID: 11039911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
    Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
    Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
    Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
    Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression.
    Cho SJ; Park JW; Kang JS; Kim WH; Juhnn YS; Lee JS; Kim YH; Ko YS; Nam SY; Lee BL
    Cancer Sci; 2008 Jun; 99(6):1117-24. PubMed ID: 18384434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
    Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells.
    Ennen M; Minig V; Grandemange S; Touche N; Merlin JL; Besancenot V; Brunner E; Domenjoud L; Becuwe P
    Free Radic Biol Med; 2011 Jun; 50(12):1771-9. PubMed ID: 21419216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.
    Delhalle S; Deregowski V; Benoit V; Merville MP; Bours V
    Oncogene; 2002 May; 21(24):3917-24. PubMed ID: 12032830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation.
    Yan HQ; Huang XB; Ke SZ; Jiang YN; Zhang YH; Wang YN; Li J; Gao FG
    Cancer Sci; 2014 Sep; 105(9):1220-7. PubMed ID: 24988892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.